假定蛋白CT440在沙眼衣原体感染细胞中的定位研究

包涵体膜蛋白在沙眼衣原体致病过程中发挥重要的作用.为确定假定蛋白CT440在沙眼衣原体感染细胞中的定位及特征,本研究采用PCR方法从D型沙眼衣原体的基因组中扩增Ct440基因,克隆入pGEX-6p原核表达载体构建pGEX-6p/Ct440原核表达重组体,重组体转化到XL1-blue大肠杆菌,IPTG诱导表达融合蛋白GST-CT440.纯化后的CT440融合蛋白免疫小鼠制备抗体,间接免疫荧光(IFA)和Western blot测定抗体的特异性.特异性抗体用于分析CT440蛋白在衣原体感染细胞内的定位、表达时相特征及其对衣原体感染的影响.结果表明,CT440蛋白定位于沙眼衣原体包涵体膜上,为沙眼衣原体包涵体膜蛋白;该蛋白在衣原体感染12h后开始表达,直至持续到整个感染周期;转基因在胞浆表达的CT440融合蛋白不影响其后的衣原体感染.本实验为深入研究衣原体与宿主细胞间的相互作用,阐明衣原体致病机制提供了重要的实验依据.     

沙眼衣原体CT058蛋白在感染细胞中的定位分析

分析沙眼衣原体CT058蛋白在感染细胞中的定位.克隆表达CT058蛋白;纯化的CT058融合蛋白免疫小鼠制备多克隆抗体;间接免疫荧光法对CT058蛋白在沙眼衣原体感染细胞中的定位进行分析;Western blot检测CT058蛋白在原体和网状体中的表达情况.间接免疫荧光染色实验显示CT058蛋白位于包涵体内;鼠抗GST-CT058抗体与GST-CT058融合蛋白吸附后特异性染色消失,而与GST-CT232融合蛋白吸附后仍然可见GST-CT058抗体的包涵体染色特征;Western blot证实CT058蛋白在纯化的原体和网状体上均有表达.CT058蛋白定位于沙眼衣原体感染细胞的包涵体内.     

CT358蛋白在沙眼衣原体感染细胞中的定位及特性分析

确定沙眼衣原体CT358蛋白在衣原体感染细胞中的位置并初步鉴定其生物学功能．采用PCR方法从D型沙眼衣原体的基因组中扩增CT358基因,并克隆入pGEX和pDSRedC1表达载体中．将重组质粒pGEX-CT358转化到XL1-blue宿主菌,并诱导表达融合蛋白GST-CT358．纯化后的CT358融合蛋白免疫小鼠制备抗体,应用间接免疫荧光技术对CT358蛋白在衣原体感染细胞内的定位及表达模式进行分析．同时,pDSRedC1-CT358重组质粒瞬时转染HeLa细胞,观察CT358蛋白对衣原体感染的影响．实验结果证明CT358蛋白为沙眼衣原体包涵体膜蛋白．该蛋白质在衣原体感染12 h后就表达定位于包涵体膜上,直至持续到整个感染周期,转基因在胞浆表达的CT358融合蛋白不影响其后的衣原体感染．该研究为深入研究衣原体与宿主细胞间相互作用提供了新的线索,并可为衣原体性的治疗、预防提供新方向．     

鹦鹉热衣原体的B598_0590基因编码包涵体膜蛋白

目的:鹦鹉热衣原体的B598_0590基因与沙眼衣原体的毒力基因CT135同源,本研究旨在分析该基因的表达和定位。方法:生物信息学方法分析B598_0590基因的进化地位,比较B598_0590蛋白和沙眼衣原体毒力蛋白CT135的氨基酸疏水特征;重组表达、纯化鹦鹉热衣原体的B598_0590蛋白,免疫小鼠制备抗血清;共聚焦免疫荧光观察鹦鹉衣原体在正常培养条件和使用Lpx C抑制剂时B598_0590基因的表达和定位。结果:衣原体属内12个种的基因组均含有CT135同源基因,它们编码的蛋白质有相似的疏水特征;B598_0590与CT135的氨基酸同源性为21%;B598_0590的免疫荧光染色特征与包涵体膜蛋白Inc A相似,浓染包涵体膜;Lpx C抑制剂可抑制网状体的分裂、包涵体的生长及网状体向原体转化,包涵体膜蛋白的染色呈现典型的空泡结构。结论:Lpx C抑制剂可用于鉴定未知的鹦鹉热衣原体包涵体膜蛋白;鹦鹉热衣原体的B598_0590基因编码此前尚未鉴定的包涵体膜蛋白。     

沙眼衣原体包涵体膜蛋白CT225与宿主波形蛋白存在相互作用

【背景】衣原体独特的发育周期是在包涵体内完成的,大约7%–10%的基因编码包涵体膜蛋白,由此可见包涵体膜蛋白可能在其发育和致病过程中发挥重要作用。然而,其具体功能仍有待深入研究。【目的】筛选包涵体膜蛋白CT225的互作分子,以期进一步了解其可能的生物学功能。【方法】首先表达融合蛋白GST-CT225,用亲和层析法从HeLa细胞裂解液中筛选CT225的互作分子,所得蛋白进行质谱分析。确定候选蛋白,然后通过免疫共沉淀方法(Co-Immunoprecipitation,CO-IP)、谷胱甘肽巯基转移酶(Glutathione S-Transferase,GST)下拉/沉降实验和亚细胞定位等方法进行验证。【结果】参考质谱分析得分,通过实验初步验证得出波形蛋白(Vimentin,VIM)为与CT225相互作用的蛋白。【结论】CT225与HeLa细胞的波形蛋白Vimentin互相作用,提示其功能可能与维持细胞骨架完整性、膜运输和脂质转运等有关。     

沙眼衣原体CT135蛋白的表达与抗体制备

目的:在原核表达系统中表达沙眼衣原体CT135蛋白,并制备抗体,建立CT135蛋白免疫检测方法。方法:将沙眼衣原体CT135基因(1083 bp)克隆入带有His标签的pET-32a(+)载体中,通过NdeⅠ/XhoⅠ双酶切构建CT135全长的重组质粒WT,CT135基因N端逐渐缩短的重组质粒MT1、MT2、MT3,以及CT135基因C端逐渐缩短的重组质粒MT4、MT5、MT6,在大肠杆菌BL21(DE3)中重组表达;用Ni2+-NTA亲和层析柱纯化重组蛋白,然后腹腔注射5周龄BALB/c雌鼠制备抗血清。结果:Western印迹使用高灵敏的二抗通过红外扫描系统检测到所有质粒可表达重组蛋白,但考马斯亮蓝染色结果显示只有MT6可高表达重组蛋白。制备纯化了MT6重组蛋白,通过腹腔注射免疫法制备了小鼠抗MT6血清。结论:大肠杆菌表达系统中,沙眼衣原体CT135蛋白的N端片段(1～374 bp)可以获得高表达。小鼠抗MT6血清的制备为后期检测沙眼衣原体CT135蛋白的表达奠定了基础。     

家蚕核型多角体病毒orf25基因在病毒感染过程中 编码一个30kDa的晚期蛋白

首次对家蚕核型多角体orf25基因进行了描述.扩增Bm25基因,亚克隆到原核表达载体pGEX-4T-2,在大肠杆菌BL21(DE3)中表达含有GST标签的融合蛋白.IPTG诱导后高效表达GST-Bm25融合蛋白.纯化的融合蛋白免疫新西兰大白兔制备多克隆抗体.利用制备的抗GST-Bm25融合蛋白的多克隆抗体进行表达时相分析显示:24 h p.i.检测到30 kDa的蛋白条带.RT-PCR方法,在18-72 h p.i 检测到Bm25基因的转录本.结论:以上数据表明Bm25基因编码一晚期表达的30kDa蛋白.     

沙眼衣原体包涵体膜蛋白的研究进展

沙眼衣原体(Chlamydia trachomatis,Ct)是一种专性细胞内寄生的革兰阴性病原体,在宿主细胞内增殖形成包涵体,通过包涵体与宿主细胞发生相互作用。包涵体膜蛋白(inclusion membrane proteins,Inc蛋白)是一类定位于衣原体包涵体膜上的含独特双叶片状疏水性基序结构的衣原体蛋白。Inc蛋白广泛存在于衣原体属各个种内,每种衣原体既有各自独特的Inc蛋白,又有其关键Inc蛋白同系物,基于生物信息学方法,预测Ct有59个Inc蛋白。Inc蛋白在衣原体与宿主细胞相互作用过程中发挥重要作用。在过去的十年内,鉴定Inc蛋白并对其功能进行研究受到了重视,但对于Inc蛋白的功能仍知之甚少。衣原体基因操控技术的应用,推动了Inc蛋白等衣原体单个蛋白的功能研究。现就Ct Inc蛋白的鉴定及其功能研究进展作一概述。     

p65蛋白的诱导表达及电子显微镜观察其显微结构

目的:构建重组原核表达载体pGEX-5x-1-p65,诱导GST-p65融合蛋白的表达并观察其包涵体的显微结构.方法:应用PCR技术扩增得到p65全长序列,并亚克隆至带有GST标签的pGEX-5x-1载体中.经酶切、测序鉴定后,在原核细胞中诱导表达GST-p65融合蛋白并将诱导后的菌体制作透射电镜标本,观察菌体内部显微结构.结果:成功构建表达载体pGEX-5x-1-p65,原核细胞中诱导表达、凝胶电泳后未见可溶性融合蛋白的高效表达.透射电镜观察到在承载有重组载体的菌体内部出现大量高电子密度的包涵体.结论:成功构建了原核表达载体pGEX-5x-1-p65,电子显微镜观察并证实在原核细胞内p65蛋白诱导表达形成包涵体.     

衣原体蛋白的亚细胞定位

沙眼衣原体(Chlamydia trachomatis,CT)是一种严格细胞内寄生、有独特发育周期的原核细胞型微生物.CT在宿主细胞浆内增殖,形成光镜可见的典型细胞内包涵体,包涵体为CT在宿主细胞内的生长繁殖提供屏障保护,同时也是CT与宿主细胞进行物质交换和信息传递的门户,CT不仅可从宿主细胞摄取营养物质,还可分泌效应蛋白进入宿主细胞质调节宿主细胞功能.CT基因组DNA序列和功能注释完成后,衣原体蛋白的亚细胞定位、结构和功能的研究已成为衣原体研究领域的热点之一[1-3].在CT与宿主细胞相互作用过程中,Inc蛋白、分泌蛋白等衣原体蛋白可能发挥着重要作用,鉴于蛋白质的亚细胞定位情况往往与其功能密切相关,衣原体蛋白在感染细胞中的定位认识成为其功能研究中的重要环节.     

Localization and characterization of the hypothetical protein CT440 in <Emphasis Type="Italic">Chlamydia trachomatis</Emphasis>-infected cells

The inclusion membrane proteins play potentially important roles in chlamydial biology and pathogenesis. Here we localized and characterized the hypothetical protein CT440 in Chlamydia trachomatis-infected cells. The open reading frame (ORF) encoding the CT440 protein from the C. trachomatis serovar D genome was cloned into the prokaryotic expression vector pGEX-6p and expressed as a glutathione-S-transferase (GST) fusion protein in E. coli XL1-Blue. The CT440 fusion protein was used to immunize mice to raise antigen-specific antibody. After verification by Western blot and immunofluorescence assay (IFA), the specific antibody was used to localize the endogenous CT440 protein and to detect its expression pattern in Chlamydia-infected cells. Cytosolic expression of CT440 in HeLa cells was also carried out to evaluate the effect of the CT440 protein on the subsequent chlamydial infection. The results showed that the hypothetical protein CT440 was localized in the C. trachomatis inclusion membrane, and was detectable 12 h after chlamydial infection. Expression of CT440 in the cytoplasm did not inhibit the subsequent chlamydial infection. In summary, we have identified a new inclusion membrane protein that may be an important candidate for understanding C. trachomatis pathogenesis.     

Localization and Characterization of GTP-Binding Protein CT703 in the <Emphasis Type="Italic">Chlamydia trachomatis</Emphasis>-Infected Cells

To localize and characterize the GTP-binding protein encoded by the chlamydial ORF CT703 in the Chlamydia trachomatis-infected cells, the gene coding for CT703 in the Chlamydia trachomatis serovar L2 genome was cloned into the prokaryotic expression vector pGEX and expressed as GST fusion protein in the E. coli BL21 strain. The GST-CT703 fusion protein was purified and used to raise antigen-specific antibodies. Using the anti-fusion protein antibodies, we localized the endogenous CT703 protein inside the chlamydial inclusion using an indirect immunofluorescence assay (IFA). We also detected a significantly decreased level of CT703 in cultures that were induced to undergo persistent infection. These observations suggest that CT703 may be an important regulator for promoting chlamydial productive infection.     

The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion

Chlamydiae replicate within an intracellular vacuole, termed an inclusion, that is non-fusogenic with vesicles of the endosomal or lysosomal compartments. Instead, the inclusion appears to intersect an exocytic pathway from which chlamydiae intercept sphingomyelin en route from the Golgi apparatus to the plasma membrane. Chlamydial protein synthesis is required to establish this interaction. In an effort to identify those chlamydial proteins controlling vesicle fusion, we have prepared polyclonal antibodies against several Chlamydia trachomatis inclusion membrane proteins. Microinjection of polyclonal antibodies against three C. trachomatis inclusion membrane proteins, IncA, F and G, into the cytosol of cells infected with C. trachomatis demonstrates reactivity with antigens on the cytoplasmic face of the inclusion membrane, without apparent inhibition of chlamydial multiplication. Microinjection of antibodies against the C. trachomatis IncA protein, however, results in the development of an aberrant multilobed inclusion structure remarkably similar to that of C. psittaci GPIC. These results suggest that the C. trachomatis IncA protein is involved in homotypic vesicle fusion and/or septation of the inclusion membrane that is believed to accompany bacterial cell division in C. psittaci . This proposal is corroborated by the expression of C. trachomatis and C. psittaci IncA in a yeast two-hybrid system to demonstrate C. trachomatis , but not C. psittaci , IncA interactions. Despite the inhibition of homotypic fusion of C. trachomatis inclusions, fusion of sphingomyelin-containing vesicles with the inclusion was not suppressed.     

A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane

Chlamydiae are obligate intracellular pathogens that spend their entire growth phase sequestered in a membrane-bound vacuole called an inclusion. A set of chlamydial proteins, labelled Inc proteins, has been identified in the inclusion membrane (IM). The predicted IncA, IncB and IncC amino acid sequences share very limited similarity, but a common hydrophobicity motif is present within each Inc protein. In an effort to identify a relatively complete catalogue of Chlamydia trachomatis proteins present in the IM of infected cells, we have screened the genome for open reading frames encoding this structural motif. Hydropathy plot analysis was used to screen each translated open reading frame in the C. trachomatis genome database. Forty-six candidate IM proteins (C-lncs) that satisfied the criteria of containing a bilobed hydrophobic domain of at least 50 amino acids were identified. The genome of Chlamydia pneumoniae encodes a larger collection of C-lnc proteins, and only approximately half of the C-lncs are encoded within both genomes. In order to confirm the hydropathy plot screening method as a valid predictor of C-lncs, antisera and/or monoclonal antibodies were prepared against six of the C. trachomatis C-lncs. Immunofluorescence microscopy of C. trachomatis-infected cells probed with these antibodies showed that five out of six C-lncs are present in the chlamydial IM. Antisera were also produced against C. pneumoniae p186, a protein sharing identity with Chlamydia psittaci lncA and carrying a similar bilobed hydrophobic domain. These antisera labelled the inclusion membrane in C. pneumoniae infected cells, confirming that proteins sharing the unique secondary structural characteristic also localize to the inclusion membrane of C. pneumoniae. Sera from patients with high-titre antibodies to C. trachomatis were examined for reactivity with each tested C-lnc protein. Three out of six tested C-lncs were recognized by a majority of these patient sera. Collectively, these studies identify and characterize novel proteins localized to the chlamydial IM and demonstrate the existence of a potential secondary structural targeting motif for localization of chlamydial proteins to this unique intracellular environment.     

Shotgun proteomic analysis of Chlamydia trachomatis

Chlamydiae are widespread bacterial pathogens responsible for a broad range of diseases, including sexually transmitted infections, pneumonia and trachoma. To validate the existence of hitherto hypothetical proteins predicted from recent chlamydial genome sequencing projects and to examine the patterns of expression of key components at the protein level, we have surveyed the expressed proteome of Chlamydia trachomatis strain L2. A combination of two-dimensional gel analysis, multi-dimensional protein identification (MudPIT) and nanocapillary liquid chromatography-tandem mass spectrometry allowed a total of 328 chlamydial proteins to be unambiguously assigned. Proteins identified as being expressed in the metabolically inert form, elementary body, of Chlamydia include the entire set of predicted glycolytic enzymes, indicating that metabolite flux rather than de novo synthesis of this pathway is triggered upon infection of host cells. An enzyme central to cell wall biosynthesis was also detected in the intracellular form, reticulate body, of Chlamydia, suggesting that the peptidoglycan is produced during growth within host cells. Other sets of proteins identified include 17 outer membrane-associated proteins of potential significance in vaccine studies and 67 proteins previously annotated as hypothetical or conserved hypothetical. Taken together, >/=35% of the predicted proteome for C. trachomatis has been experimentally verified, representing the most extensive survey of any chlamydial proteome to date.     

GST/ AEP 融合蛋白原核表达载体的构建、表达及鉴定

目的：为进一步研究抗癫痫肽（And—epilepsy peptide,AEP）的抗痫机制及筛选其相关作用蛋白,进行GST／AEP融合蛋白原核表达载体的构建及融合蛋白的表达。方法：通过PCR基因扩增对AEP基因进行扩增,并将其克隆于谷胱甘肽-S-转移酶（GST）融合蛋白表达质粒pGEX-4T-1中,经酶切、序列鉴定分析后,用该重组质粒转化大肠杆菌B121（DE3）,经IPTG诱导获得表达,并采用Western Blot进行检测。结果：成功构建了AEP原核表达载体,并在大肠杆菌B121中获得表达。结论：成功构建了GST／AEP原核表达载体,并表达了GST／AEP融合蛋白。